DURBAN, South Africa (July 18, 2016) — New data analyses announced at the AIDS 2016 conference today provide additional evidence suggesting that the monthly dapivirine vaginal ring developed by the

More than Thirty participants have completed the 2016 Uganda Advanced Statistical Methods in Epidemiology Course, organized by the MRC/UVRI Uganda Research on AIDS.

As part of its capacity building programme, the Entebbe based Uganda Virus Research Institute (UVRI) together with her partner institutions which include Medical Research Council/ Uganda Virus Rese

Two of the Unit’s senior scientists have been recognized for their contribution to the fight against HIV/AIDS.

HIV Vaccine Awareness Day (HVAD) is observed annually on May 18th and provides an opportunity to recognize and thank the many volunteers, community members, health professionals, and scientists who

3rd May was World Asthma Day and the Unit commemorated it at an event held at Grade A Hospital gardens.

Uganda has received an award from the MRC Zika Response Initiative to determine if the country is vulnerable to a Zika virus epidemic.

Work from the Unit's Social Science programme has been listed in the Directory of Research on Ageing in Africa: 2004-2015.

The Ring Study and ASPIRE - have shown that a monthly vaginal ring containing the antiretroviral drug (ARV) dapivirine can safely help prevent HIV-1 infection in women and may be an important HIV p

On 29th October 2015, the Unit launched the "HIV prevention and research in Uganda Police Force" programme.

The MRC/UVRI Uganda Research Unit on AIDS has been recognized as a leader in HIV & AIDS Research at the inaugural HIV/AIDS Leadership Awards.

Seven leading African researchers are the recipients of major funding from the Wellcome Trust and the Department for International Development (DFID) to establish cutting-edge research and training